Mark Andrew Sherman Sells 9,109 Shares of Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories (NYSE:DLB) EVP Mark Andrew Sherman sold 9,109 shares of the firm’s stock in a transaction dated Tuesday, December 16th. The stock was sold at an average price of $66.73, for a total value of $607,843.57. Following the sale, the executive vice president directly owned 73,054 shares in the company, valued at $4,874,893.42. This trade represents a 11.09% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Mark Andrew Sherman also recently made the following trade(s):

• On Wednesday, December 17th, Mark Andrew Sherman sold 2,491 shares of Dolby Laboratories stock. The shares were sold at an average price of $67.26, for a total value of $167,544.66.
• On Monday, December 1st, Mark Andrew Sherman sold 4,500 shares of Dolby Laboratories stock. The stock was sold at an average price of $67.56, for a total transaction of $304,020.00.

Dolby Laboratories Trading Down 0.6%

Shares of NYSE:DLB opened at $66.74 on Friday. The firm has a 50 day simple moving average of $66.82 and a 200-day simple moving average of $71.22. Dolby Laboratories has a twelve month low of $64.02 and a twelve month high of $89.66. The company has a market capitalization of $6.37 billion, a PE ratio of 25.38 and a beta of 0.89.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings results on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, topping the consensus estimate of $0.70 by $0.29. Dolby Laboratories had a net margin of 18.90% and a return on equity of 11.99%. The firm had revenue of $307.02 million for the quarter, compared to analyst estimates of $305.76 million. During the same period last year, the business earned $0.61 EPS. Dolby Laboratories’s revenue for the quarter was up .7% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. As a group, equities research analysts predict that Dolby Laboratories will post 2.94 EPS for the current fiscal year.

Dolby Laboratories Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd were issued a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend was Tuesday, December 2nd. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s dividend payout ratio (DPR) is presently 54.75%.

Hedge Funds Weigh In On Dolby Laboratories

Several institutional investors have recently bought and sold shares of DLB. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in shares of Dolby Laboratories by 7.8% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 15,777 shares of the electronics maker’s stock valued at $1,172,000 after purchasing an additional 1,146 shares during the period. Comerica Bank increased its holdings in Dolby Laboratories by 83.2% in the first quarter. Comerica Bank now owns 105,570 shares of the electronics maker’s stock valued at $8,478,000 after buying an additional 47,936 shares in the last quarter. Ethic Inc. acquired a new stake in shares of Dolby Laboratories during the 1st quarter valued at approximately $536,000. Martingale Asset Management L P purchased a new stake in shares of Dolby Laboratories during the 1st quarter worth approximately $15,366,000. Finally, Campbell & CO Investment Adviser LLC grew its holdings in shares of Dolby Laboratories by 193.2% in the 2nd quarter. Campbell & CO Investment Adviser LLC now owns 17,275 shares of the electronics maker’s stock worth $1,283,000 after acquiring an additional 11,384 shares during the period. 58.56% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

DLB has been the topic of a number of research reports. Barrington Research dropped their price target on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 19th. Robert W. Baird initiated coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They set a “neutral” rating and a $74.00 target price on the stock. Rosenblatt Securities cut their target price on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating on the stock in a report on Wednesday, November 19th. Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday. Three investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Dolby Laboratories presently has an average rating of “Moderate Buy” and a consensus target price of $92.00.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.